Venture Capital Firm | Contact, Portfolio & Investment Focus
series-a
$50M
$26M
Converge Fund III, LP focuses on series-a investments, targeting companies at this specific growth phase.
Check size information is not publicly disclosed. Reach out directly to discuss investment amounts.
Primary focus on Pooled Investment Fund. This specialization allows deep expertise and network effects within the sector.
Nilanjana Bhowmik; Maia Heymann; Anshu Agarwal
Massachusetts, centered around Boston and Cambridge, is the nation's biotech and life sciences capital with world-class research institutions.
Visit Converge Fund III, LP's official website to find their contact information and pitch submission process.
Converge Fund III, LP's typical check size is not publicly disclosed. Contact the firm directly for investment range details.
Converge Fund III, LP focuses on series-a investments. Companies at this stage typically have established product-market fit and are ready to scale.
Yes, Converge Fund III, LP is actively deploying capital and reviewing new investment opportunities.
Converge Fund III, LP is headquartered in CAMBRIDGE, MA. They may consider investments from startups outside their immediate geography.
Yes, Converge Fund III, LP accepts pitch submissions through their website. Visit their site to find their submission form or founder portal.
Underscore.VC Fund III, L.P.
series-a
Adara Ventures IV, FCRE
series-a
Valspring Capital Fund I, L.P.
growth
VXI Capital Fund I LP
series-a
GREYLOCK 17 PRINCIPALS LP
unknown
GREYLOCK 17 LIMITED PARTNERSHIP
unknown
Data Sources: SEC EDGAR filings, company disclosures, and verified public records.
Last updated: Aug 25, 2023